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The objective of this review was to assess the effectiveness of bystander naloxone administration and overdose
education programs by synthesizing quantitative results reported in the research literature. Studies meeting
predefined criteria were identified and reviewed, and their results were synthesized through meta-analysis. Odds
ratios (ORs) and 95% confidence intervals (CIs) were calculated for overdose recoveries for individuals who received
naloxone dispensed by non-medical community members, and the standardized mean difference was calculated
for test scores of non-medical volunteers who received training in overdose management versus the scores of
untrained volunteers. Pooled data from four studies showed that naloxone administration by bystanders was
associated with a significantly increased odds of recovery compared with no naloxone administration (OR = 8.58,
95% CI = 3.90 to 13.25). Data from five studies of overdose education indicated that average scores were significantly
higher for trained participants than untrained participants for tests on naloxone administration, overdose recognition,
and overdose response (standardized mean difference = 1.35, 95% CI = 0.92 to 1.77). Empirical evidence in the research
literature suggests that bystander naloxone administration and overdose education programs are associated with
increased odds of recovery and with improved knowledge of overdose recognition and management in
non-clinical settings.
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Introduction
The population-based death rate from drug overdose in
the United States has increased dramatically over the
last two decades, primarily due to an increase in deaths
involving opioid analgesics (CDC 2014a,b,c). In 2013
(the last year for which data are available), national data
indicate that drug overdose claimed 43,982 lives, 81.1%
of which were coded as unintentional (CDC. National
vital statistics system mortality data 2015). Overdoses in-
volving opioid analgesics accounted for 36.9% of all drug-
poisoning deaths (CDC. National vital statistics system
mortality data 2015).
Opioid overdose deaths are avoidable if the antagonist
naloxone is administered in time. Naloxone has been the
standard treatment for overdose effects like respiratory* Correspondence: Charles.DiMaggio@nyumc.org
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in any medium, provided the original work is pdepression, sedation, and hypotension in the emergency
department setting for the past 3.5 decades (Kim et al.
2009). In 1996, community-based overdose prevention
programs began distributing naloxone to high risk opi-
oid users (CDC 2012).
There is a general consensus in the literature on the
safety and effectiveness of naloxone when administered
by health professionals (Sporer 1999). Naloxone has few
known adverse effects, has no potential for abuse, and is
available at a reasonably low cost (Maxwell et al. 2006),
although there has been recent concern over cost increases.
Some states have experienced increases of more than 50%.
For example, the price of a naloxone kit in Georgia, ori-
ginally $22, has spiked to $40 (Goodman 2014).
The effectiveness of naloxone is entirely time depen-
dent. Death typically occurs within 1 to 3 hours after an
overdose (Kim et al. 2009). Thus, naloxone is only suc-
cessful in reversing an overdose if administered before
overdose symptoms cause death. Medical first responders
and emergency departments are equipped with naloxone.n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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arrive too late to revive overdose victims.
Bystanders may be reluctant to call 911 because of fear
of police involvement (in many communities, police re-
spond to 911 calls with EMS) (Kim et al. 2009). Even
when a bystander’s call is immediate, transportation time
adds delays. These time costs may be avoided when
naloxone is available at the scene of the overdose, for
example, in the hands of drug users and their social net-
works. Harm reduction workers have resolved to equip
opioid users and their community with the antidote
(Kim et al. 2009).
Since their introduction, naloxone distribution pro-
grams have prompted both ethical and legal concerns.
Some critics have argued that possession of naloxone
could increase reckless drug use, if users considered na-
loxone a ‘safety net’ against the fatal consequences of use
(Seal et al. 2003). Research evidence generally contra-
dicts this claim, as studies have found that participants
in naloxone programs report decreased use at follow-up
and/or an intention to actively avoid the risk of overdose
in the future (Seal et al. 2005, Bigg 2002). Critics have
also questioned whether or not drug users and commu-
nity members can be trusted to safely and adequately re-
spond to overdoses.
This study presents a systematic review of the lite-
rature on bystander and non-medical administration of
naloxone, synthesizes the effect estimates of studies re-
porting quantitative outcomes, and reports on the ef-
fectiveness of naloxone administration by bystanders in
reversing overdoses as well as whether overdose response
training increases knowledge of overdose recognition and
management. The objective of this study is to synthesize
the quantitative findings of available studies to generate a
summary estimate of the effectiveness of such programs
using meta-analytic methods.
Methods
This study followed the guidelines for conducting sys-
tematic reviews and meta-analyses of observational epi-
demiological studies, as outlined in the meta-analysis of
observational studies in epidemiology (MOOSE) guidelines
(Stroup et al. 2000).
Search and ICD-10 coding
We electronically searched PubMed and additional sources
for published studies using the following search terms:
use*, using, addict*, disorder*, naloxon*, narcan*, evizo,
OEND, OOPP, THN, overdose, overdos*, educat*, train*,
untrain*, un-train*, nontrain*, non-train*, and program*.
The articles were entered into the Endnote bibliographic
management software program (Reuters, 2013). Abstracts
and titles were electronically searched in Endnote for the
terms naloxone, opioid antagonist, overdose, distribution,and program. Visual inspection identified animal studies,
pharmacological studies, and treatment program studies
for exclusion. Full-text versions were reviewed by the pri-
mary author and coded for naloxone recovery and death
rates, as well as the following training variables: naloxone
administration knowledge, overdose response knowledge,
and overdose recognition knowledge.
Inclusion criteria consisted of studies quantitatively
measuring the impact of overdose prevention program
training sessions on the knowledge of community mem-
bers. Training material had to cover, at minimum, naloxone
administration, for example, the intranasal administration
technique and other overdose response strategies, such as
calling 911 or using rescue breathing. Eligible studies
compared individuals who had been trained in prevention
programs to individuals who had not yet been trained in a
program at the time of their participation in the study. Eli-
gible studies clearly defined their participant population.
Articles on naloxone distribution programs were ex-
cluded from this analysis if they did not distinguish be-
tween naloxone administration by emergency personnel
and naloxone administration by lay people or did not
report one of the following outcomes: recoveries with
naloxone, recoveries without naloxone, deaths with na-
loxone, and deaths without naloxone. Articles on overdose
prevention training were excluded if they did not report
a mean untrained participant test score and a mean
trained participant test score or if these numbers were
not deducible.
For both the analysis of overdose reversal and the ana-
lysis of training effectiveness, randomized control trials,
cohort studies, or cross-sectional analyses with validated
measures were included. Included studies were required
to include a control group, either of untrained partici-
pants or of participants prior to training. All eligible
studies reported at least one quantitative outcome meas-
ure of overdose prevention skills learned. These mea-
sures could be objective tests of knowledge or skills
acquired in training or subjective reports of perform-
ance. Only studies from which an effect size could be
computed were included. All studies had to be written
or translated into English, in order to be comprehensible
to the researchers.
Studies were included in the analyses if they reported
on programs which trained lay community members in
overdose management. Therefore, trained participants
could be defined as substance users, family and friends
of substance users, or community members with no
direct relation to substance users. Trained participants
could not include health care professionals, EMTs, or
police officers, as this study aimed to evaluate the ef-
fectiveness of these programs in training members of
the community with no medical or emergency service
experience.
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A quality appraisal was conducted to assess the methods
of all studies which reported the necessary outcomes
and otherwise fulfilled the inclusion criteria. The quality
appraisal was adapted from the assessment of quantita-
tive studies scale created by Jinks et al. (2011), which has
been implemented by other studies (Clark et al. 2014).
The articles were rated on eight items. A perfect score
was an 8/8.
Implementation of the scale differed slightly from
implementation by Clark et al. (2014). This was only
relevant for the rating of the study by Lankenau et al.
(2013). This discrepancy can be attributed to slight dif-
ferences in scoring. Clark used a separate randomization
criterion for qualitative studies, whereas this study evalu-
ated both qualitative and quantitative studies using the
criterion provided by Jinks et al. (2011). Additionally,
Clark used a scale of 0, 0.5, and 1, while this study gave
ratings of either 0 (for absent criteria) or 1 (for present
criteria). The primary author of this study was blind to
Clark’s ratings when assessing articles.
Data analysis
Studies were grouped by the outcome reported, either
dichotomous (naloxone success rate) or continuous
(average training score). Results were tabulated and ef-
fect sizes were calculated. For the dichotomous naloxone
effectiveness outcome, odds ratios were computed based
on the reported naloxone success rates. For the training
effectiveness outcome, standardized mean differences
were calculated based on the reported average training
scores. Fixed and random effects models were devel-
oped, and statistical significance at 95% confidence inter-
vals was computed. A random effects model was most
appropriate for this analysis because of its implications
for generalizability. The fixed effects model assumes that
the included studies are functionally identical and there-
fore would only describe naloxone distribution program
participants. The random effects model provides a more
conservative estimate because it accounts for between-
study variance. In this model, we added the following
term to account for between-study variance: (Q-k-1)/
SUM(w)-(SUM(w2)/SUM(w)), where Q is the Q statistic
based on chi squared, k is the number of studies, and w
is the weight for each individual study. However, since
the number of studies in this analysis is small, the random
effects model cannot estimate between-study variance
with much precision (Borenstein et al. 2009). We included
both models to show that the summary estimate is not
greatly influenced by model choice.
Heterogeneity was assessed using the Q statistic by
Cochran (1954) and the I2 index by Higgins and Thomp-
son (2002). The Q statistic indicates whether heterogeneity
is statistically significant whereas the I2 statistic quantifiesthe extent of heterogeneity. The latter reveals the propor-
tion of variability in a meta-analysis that is the result of
between-study variation and not error within studies due
to random sampling. I2 ranges from 0% to 100%, higher
percentages indicating substantial heterogeneity (Huedo-
Medina et al. 2006).
All analyses were conducted using Comprehensive
Meta-Analysis version 2 and the R statistical computing
platform (Biostat Inc., Englewood, NJ, USA).
Results
A total of 785 studies were identified through database
searching, and six additional studies were identified
through other sources. Of these, three duplicates were
removed (see Figure 1). Because no article received a low
quality rating, no article was eliminated from this study
on the basis of its quality rating (see Table 1).
Description of included studies
Four studies contributed to the analysis on bystander
naloxone administration (Strang et al. 2008; Lankenau
et al. 2013; McAuley et al. 2010; Galea et al. 2006). Nalox-
one outcomes were defined as ‘recoveries with naloxone,’
‘recoveries without naloxone,’ ‘deaths with naloxone,’
and ‘deaths without naloxone.’ Lay-dispensed naloxone
outcomes were based on participant self-reports from
witnesses of overdoses. Participants indicated who ad-
ministered naloxone and whether or not the victim was
revived. McAuley et al. (2010) was the only study to not
rely on self-report. For all studies, self-reports were
confirmed with police and ambulance data (see program
characteristics in Table 2).
Five studies contributed to the analysis on training
effectiveness (Green et al. 2008; McAuley et al. 2010;
Williams et al. 2014; Gaston et al. 2009; Jones et al. 2014)
(see program characteristics in Table 3). Training out-
comes were defined as ‘trained participant training score’
and ‘untrained participant training score.’ McAuley et al.
(2010) was the only study to report both naloxone
and training outcomes. Strang et al. (2008) and Gaston
et al. (2009) report on the same sample at different
time periods and are therefore discussed here as a
single study.
Training outcomes were measured by comparing the
test scores of those who had completed training with
those who had not. In all but one study, the training out-
come was a comparison of pre- and post-training scores
completed by the same group of participants. In Green
et al. (2008), the trained and untrained participants were
distinct samples (the untrained participants did not go
on to be trained).
All training programs briefed participants on naloxone
distribution (for example, how to assemble the applicator
and release naloxone) and overdose response (calling 911,
Figure 1 PRISMA flow diagram of identification of articles for inclusion adapted from Moher et al. (2009).
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All but one study discussed overdose recognition (McAuley
et al. 2010). Program duration ranged from around 13
to 90 min. Three studies did not report program dur-
ation (Lankenau et al. 2013; McAuley et al. 2010; Strang
et al. 2008).
Many studies neglected to report the curriculum
models and evaluation tools used to develop these pro-
grams. Therefore, although we can determine that con-
tent was similar, other aspects of the training sessions,
such as training methods for delivering the content, the
duration of the session, and evaluation protocol may
have differed across programs. Of the four studies that
did name papers or organizations which influenced the
development of the training curriculum, there was no
overlap among curriculum models. Regarding evalua-
tion tools, the Brief Overdose Recognition and Res-
ponse Assessment (BORRA) scale (Green et al. 2006)
was referenced by two studies. Williams et al. (2014)
cited their own scales. The other four studies dis-
cussed questionnaire and interview assessment items
but did not include citations (Gaston et al. 2009; Strang
et al. 2008; Lankenau et al. 2013; McAuley et al. 2010;
Galea et al. 2006).Quantitative results
Summing across all four studies of naloxone lay admin-
istration effectiveness, a total of 66 witnessed overdose
events were reported. Of the 66 witnessed events, 39
(59.1%) recovered after naloxone was administered by
a lay participant and 22 (33.3%) recovered without
the administration of naloxone. There were no deaths
among the 39 instances when naloxone was adminis-
tered. There were three deaths among the 27 instances
when naloxone was not administered, for an 11.1% mor-
tality rate. The outcome of two witnessed events (3%) was
unknown.
For the four studies of naloxone lay administration ef-
fectiveness (Strang et al. 2008; Lankenau et al. 2013;
McAuley et al. 2010; Galea et al. 2006), the summary
odds ratio measuring the strength of the association be-
tween naloxone administration and recovery based on the
data reported was 8.58 (95% confidence interval (CI) =
3.90 to 13.25, I2 = 92.09%), indicating a statistically signifi-
cant but highly heterogeneous effect (see Figure 2).
Of the five studies that reported training outcomes
(Green et al. 2008; McAuley et al. 2010; Williams et al.
2014; Gaston et al. 2009; Jones et al. 2014) (see Figure 3),
the overall average scores were significantly higher for
Table 1 Quality ratings of included studies
Authors Research questions/
objectives/hypothesis
are clear and appropriate
Clear overview of
intervention is given





















Williams et al. (2014) 1 1 1 1 1 1 1 1 8
Gaston et al. (2009)a 1 1 1 0 1 1 1 1 7
Strang et al. (2008)a 1 1 1 0 1 1 1 1 7
Green et al. (2008) 1 1 1 0 N/A 1 1 1 6
Jones et al. (2014) 1 1 1 0 N/A 1 1 1 6
Lankenau et al. (2013) 1 1 1 0 [0.5] N/A 1 0 [0.5] 1 6
McAuley et al. (2010) 1 1 1 0 1 1 1 1 7
Galea et al. (2006) 1 1 1 0 1 1 1 1 7












Table 2 Characteristics of the programs in the meta-analysis on bystander naloxone administration
Study Program site(s) Subjects Follow-up(s) Study design
Strang et al. 2008a Birmingham Users 3 months Prospective cohort
London
Lankenau et al. 2013 Los Angeles Users NR Cross-sectional
McAuley et al. 2010 Lanarkshire High risk users 2 months Cohort
6 months
Galea et al. 2006 New York City Users 3 months Cohort
aStrang et al. (2008) uses the same sample as Gaston et al. (2009).
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that covered overdose prevention material (naloxone
administration, overdose recognition, overdose response)
(standardized mean difference = 1.35, 95% CI = 0.92 to
1.77, I2 = 0.00%).
Discussion
Lay administration of naloxone is increasingly being
used as a response to the epidemic of opioid-related fa-
tality in the United States. In this review, we found that
such administration was both safe and effective and that
these programs are equipped to train participants in
overdose management protocol.
A systematic review of community opioid overdose
prevention and naloxone distribution programs was re-
cently published (Clark et al. 2014), and qualitative data
has been summarized (CDC 2012). Our study adds to
these results by synthesizing quantitative findings on the
effectiveness of bystander naloxone distribution and
overdose education. Our findings offer support for the
World Health Organization’s consensus report in favor
of naloxone distribution and gives further reason to
proceed with the guidelines developed by their report,Table 3 Characteristics of the programs in the meta-analysis
Study Program site(s) Subjects





McAuley et al. 2010 Lanarkshire High risk users
Williams et al. 2014 London Family/friends of u
Kent
Herefordshire
Gaston et al. 2009a Birmingham Users
London
Jones et al. 2014 New York City Users
aGaston et al. (2009) uses the same sample as Strang et al. (2008).
bPost-training test administered immediately after training.which include expanding the availability of naloxone to
lay people (WHO 2014).
Both of the analyses in our study favor the treatment,
overdose prevention training, and lay naloxone adminis-
tration. Our findings imply that lay-dispensed naloxone
is effective in treating overdose and that training has
been successful in improving participant knowledge of
overdose recognition and management.
The results imply that such programs are equipped to
train non-medical community members to respond to
overdose events. As previous studies have suggested, lay
community members can be trusted to safely and ad-
equately dispense naloxone to victims. By combining the
results of small-N studies, these meta-analyses disambigu-
ate the literature on these programs.
Although empirical findings support naloxone distribu-
tion, legal barriers at the state level have stood in the way
of implementation of these programs across the nation.
Further research should compare the success of programs
in states which have removed these legal barriers to the
success of programs in states where these barriers remain.
Although many states have updated their laws to allow na-
loxone distribution, there are still programs operating inon training effectiveness
Follow-up(s) Study design
N/A Cross-sectional
2 months 6 months Cohort
sers 3 months Randomized controlled trial
3 months 6 months Cohort
N/Ab Cohort
Test for heterogeneity: Chi-square= 34.77, df=3, p<.0001, I2= 92.09%
Test for overall effect: 8.58, z=3.60, p<0.0001
n = number recoveries  
N = number of times naloxone was or was not administered
*Strang et al. (2008) uses the same sample as Gaston et al. (2009)






















 9.54 [  7.04 , 12.05 ]
15.00 [ 12.06 , 17.94 ]
 4.20 [  1.66 ,  6.74 ]
 5.73 [  3.16 ,  8.29 ]
 8.58 [  3.90 , 13.25 ]










Figure 2 Estimated odds ratios of recovery from drug overdose associated with naloxone administration by bystanders.
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There are also programs in states which permit naloxone
distribution but have yet to adopt a 911 Good Samaritan
law, which gives legal protection to non-medical indi-
viduals who provide emergency assistance (Davis 2014).Test for heterogeneity: Chi-square= 1.02, df=4, p=0.91, I2= 0.00%
Test for overall effect: 1.35 z=6.26 p<0.0001

























Author Year Trained N Untrained N
Figure 3 Mean difference in training knowledge score between trained anIt is crucial to assess how overdose prevention pro-
grams operate in these climates in order to determine
the effects of legal barriers on the success of naloxone
distribution and overdose education programs across the
nation.1.50 2.00 2.50 3.00
 mean difference
1.62 [ 0.68 , 2.55 ]
1.42 [ 0.52 , 2.31 ]
1.13 [ 0.36 , 1.90 ]
1.63 [ 0.36 , 2.91 ]
1.13 [ 0.11 , 2.16 ]
1.35 [ 0.92 , 1.77 ]
1.35 [ 0.92 , 1.77 ]
SMD 95%-CI
d untrained participants.
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There was substantial heterogeneity in the meta-analysis
of lay administration of naloxone. The high heterogen-
eity between studies is likely due to the wide range of
total overdose events reported among the four studies.
For the training outcome, the participant population was
the same for all but one study, which observed family
and caregivers of users instead of opioid users them-
selves (Williams et al. 2014). In addition, some studies
only included responses regarding naloxone administra-
tion into the calculation of mean scores. Other studies
pooled responses on naloxone administration with re-
sponses on other material, such as overdose recognition
and response. Finally, the majority of the participants in
these studies were self-identified heroin users or their
families and peers, without medical training. Therefore,
results from this meta-analysis may not be directly
generalizable to opioid users or healthcare practitioners.
Despite these limitations, this study provides a much-
needed estimate of the benefits and risks associated with
lay administration.
Conclusions
In conclusion, our findings support overdose education
and lay administration of naloxone as a safe and effective
community-based approach to controlling the opioid
overdose epidemic. Both meta-analyses favor the treat-
ment, suggesting that lay naloxone administration and
overdose training are associated with increased odds of
recovery and increased knowledge of overdose recogni-
tion and management. These findings can inform policy
decisions as policy-makers consider whether or not to
expand these initiatives.
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